34
The Midwest Society for The Midwest Society for Behavioral Medicine and Behavioral Medicine and Biofeedback (MSBMB) Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate CSO, Brain Science International CSO, Brain Science International [email protected]

The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Embed Size (px)

Citation preview

Page 1: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

The Midwest Society for The Midwest Society for Behavioral Medicine and Behavioral Medicine and Biofeedback (MSBMB) Biofeedback (MSBMB)

DSM-5 and Biomarkers/PhenotypesDSM-5 and Biomarkers/Phenotypes

Jay Gunkelman, QEEG-DiplomateJay Gunkelman, QEEG-Diplomate CSO, Brain Science InternationalCSO, Brain Science International

[email protected]

Page 2: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

The modern dilemma in psychology: The modern dilemma in psychology:

Diagnosis, when the DSM is being Diagnosis, when the DSM is being abandoned by the author.abandoned by the author.

Page 3: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 4: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Top-down changeTop-down change

Page 5: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Reliability but no ValidityReliability but no Validity

Page 6: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

The The Research Domain Criteria (RDoC) project project transforms diagnosis by incorporating genetics, transforms diagnosis by incorporating genetics, imaging, cognitive science, and other levels of imaging, cognitive science, and other levels of

information, forming a foundation for a new information, forming a foundation for a new classification system.classification system.

““That is why NIMH will be re-orienting its research That is why NIMH will be re-orienting its research away from DSM categoriesaway from DSM categories. Going forward, we will . Going forward, we will be supporting research projects that look across be supporting research projects that look across current categories – or sub-divide current current categories – or sub-divide current categories – to begin to develop a better system.”categories – to begin to develop a better system.”

Page 7: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

“ “RDoC, for now, is a research RDoC, for now, is a research framework, not a clinical tool. This is framework, not a clinical tool. This is a decade-long project that is just a decade-long project that is just beginning. … beginning. … RDoC is nothing less RDoC is nothing less than a plan to transform clinical than a plan to transform clinical practice by bringing a new practice by bringing a new generation of research to inform how generation of research to inform how we diagnose and treat mental we diagnose and treat mental disorders.”disorders.”

Page 8: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

The DSM is based on behaviorThe DSM is based on behavior

The linkage from genetics to The linkage from genetics to behavior is indirectbehavior is indirect

The intermediate step between The intermediate step between genetics and behavior is the genetics and behavior is the phenotypephenotype

Behaviorally driven therapy can Behaviorally driven therapy can succeed, but is it optimized?succeed, but is it optimized?

Page 9: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Prior studies using EEG have Prior studies using EEG have documented “clusters” of documented “clusters” of EEG/qEEG features within EEG/qEEG features within psychiatric populations psychiatric populations

John ER, et al. Subtyping of Psychiatric Patients by Cluster Analysis of QEEG. John ER, et al. Subtyping of Psychiatric Patients by Cluster Analysis of QEEG. Brain Topography 1992; 4:321-326). Brain Topography 1992; 4:321-326).

Chabot, R. J., & Serfontein G. (1996). Quantitative electroencephalographic Chabot, R. J., & Serfontein G. (1996). Quantitative electroencephalographic profiles of children with attention deficit disorder. profiles of children with attention deficit disorder. Biological Psychiatry, 40,Biological Psychiatry, 40, 951-963. 951-963.

Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, De Caria CM, & Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, De Caria CM, & Levine RH. (1993) Quantitative electroencephalographic subtyping of Levine RH. (1993) Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. obsessive-compulsive disorder. Psychiatry Research, 50Psychiatry Research, 50(1), 25-32.(1), 25-32.

Prichep LS, & John ER. (1992). QEEG profiles of psychiatric disorders. Prichep LS, & John ER. (1992). QEEG profiles of psychiatric disorders. Brain Brain Topography, 4Topography, 4(4), 249-257.(4), 249-257.

Suffin SC, & Emory WH. (1995). Neurometric subgroups in attentional and Suffin SC, & Emory WH. (1995). Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic affective disorders and their association with pharmacotherapeutic outcome. outcome. Clinical Electroencephalography, 26, 76-83.Clinical Electroencephalography, 26, 76-83.

Page 10: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

The underlying assumption in the The underlying assumption in the DSM is: “diagnosis, thus treatment”DSM is: “diagnosis, thus treatment”

The DSM does The DSM does notnot yield optimal treatment yield optimal treatment efficacy following diagnosis efficacy following diagnosis

Diagnoses have multiple “EEG subtypes”, but Diagnoses have multiple “EEG subtypes”, but they they ARE NOT SPECIFICARE NOT SPECIFIC TO THE DIAGNOSISTO THE DIAGNOSIS

Frontal alpha in ADDFrontal alpha in ADD Frontal alpha in depressionFrontal alpha in depression Frontal alpha in early dementiaFrontal alpha in early dementia Frontal alpha in anxietyFrontal alpha in anxiety Frontal alpha in OCDFrontal alpha in OCD

Page 11: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Phenotypic patterns are Phenotypic patterns are notnot isomorphic with the DSM categoriesisomorphic with the DSM categories

Phenotypes have powerful Phenotypes have powerful

implications for both medication, and implications for both medication, and Neurofeedback.Neurofeedback.

Wright, C, & Gunkelman J. (1998). QEEG evaluation doubles the rate of clinical Wright, C, & Gunkelman J. (1998). QEEG evaluation doubles the rate of clinical success. success. Abstracts of the 6th Annual Conference, Abstracts of the 6th Annual Conference, Society for the Study of Society for the Study of Neuronal Regulation, Austin, TX.Neuronal Regulation, Austin, TX.

Suffin SC, & Emory WH. (1995). Neurometric subgroups in attentional and Suffin SC, & Emory WH. (1995). Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic affective disorders and their association with pharmacotherapeutic outcome. outcome. Clinical Electroencephalography, 26, 76-83.Clinical Electroencephalography, 26, 76-83.

Johnstone, J., Gunkelman, J.,& Lunt, J.. (2005). Clinical database development: Johnstone, J., Gunkelman, J.,& Lunt, J.. (2005). Clinical database development: Characterization of EEG Phenotypes. Characterization of EEG Phenotypes. Clinical EEG and Neuroscience, 2Clinical EEG and Neuroscience, 2, 99-, 99-107.107.

Page 12: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Phenotypes have led to enhanced Phenotypes have led to enhanced outcomes clinicallyoutcomes clinically

S. Suffin and H. Emory (attentional and affective, S. Suffin and H. Emory (attentional and affective, medication)medication)

L. Prichep (OCD, medication)L. Prichep (OCD, medication)

Chabot, et al. (ADD/ADHD, medication)Chabot, et al. (ADD/ADHD, medication)

C. Wright (ADD/ADHD, Neurofeedback)C. Wright (ADD/ADHD, Neurofeedback)

M.I.N.D. (U.C. Davis, Autism)M.I.N.D. (U.C. Davis, Autism)

Databases for EEG are starting to include the genetic Databases for EEG are starting to include the genetic component (Brain Resource Company, Australia)component (Brain Resource Company, Australia)

Page 13: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Some EEG patterns have Some EEG patterns have strongstrong genetics linksgenetics links

Low voltage EEGLow voltage EEG Enoch, MA, et al. (2002). The relationship between two intermediate phenotypes for , et al. (2002). The relationship between two intermediate phenotypes for

alcoholism: Low voltage alpha EEG and low P300 ERP amplitude. alcoholism: Low voltage alpha EEG and low P300 ERP amplitude. Journal of Studies on Journal of Studies on Alcohol, 63Alcohol, 63(5), 509-17.(5), 509-17.

Porjesz B, et al. (2002). Linkage disequilibrium between the beta frequency of the Porjesz B, et al. (2002). Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus. Proceedings of the National Academy human EEG and a GABAA receptor gene locus. Proceedings of the National Academy of Sciences of the United States of America; 99(6): 3729-3733.of Sciences of the United States of America; 99(6): 3729-3733.

Gunkelman J. (2001). Low voltage or absolute power. Journal of Neurotherapy; 5:1-2.Gunkelman J. (2001). Low voltage or absolute power. Journal of Neurotherapy; 5:1-2.

Epileptiform burstsEpileptiform bursts Kaneko S., Iwasa H., & Okada M. (2002). Genetic identifiers of epilepsy. Kaneko S., Iwasa H., & Okada M. (2002). Genetic identifiers of epilepsy. Epilepsia, 43 Epilepsia, 43

((Suppl 9), 16-20.Suppl 9), 16-20.

Huag K, et al. (2003) Mutations in CLCN2 encoding a voltage-gated chloride channel Huag K, et al. (2003) Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nature Genetics; 33:527-532.are associated with idiopathic generalized epilepsies. Nature Genetics; 33:527-532.

Page 14: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

A limited set of phenotypic divergence A limited set of phenotypic divergence patterns can characterize the bulk of the patterns can characterize the bulk of the

variance of the EEGvariance of the EEG

These EEG phenotypes predict effective These EEG phenotypes predict effective therapy therapy

(medication and NF)(medication and NF)

The following table is not a substitute for professional evaluation and The following table is not a substitute for professional evaluation and consultationconsultation

Page 15: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

EpileptiformEpileptiform Transient spike/wave, sharp waves, paroxysmal EEG Transient spike/wave, sharp waves, paroxysmal EEG

Anticonvulsant medicationAnticonvulsant medicationInhibit low and high frequencies over affected regions, reward SCP and/or SMR.Inhibit low and high frequencies over affected regions, reward SCP and/or SMR.

Generally low magnitudes (fast or slow) Generally low magnitudes (fast or slow) Metabolic support (LVS), nutraceuticals Metabolic support (LVS), nutraceuticals Reward alpha activity posteriorly. (Penniston protocol for LVF)Reward alpha activity posteriorly. (Penniston protocol for LVF)

Faster alpha variants, not low voltageFaster alpha variants, not low voltage Alpha frequency greater than 12 Hz over posterior cortex. Alpha frequency greater than 12 Hz over posterior cortex.

GABA related medication (slightly slows the EEG frequencies)GABA related medication (slightly slows the EEG frequencies) Reward 9-10Hz alpha at Pz, shift alpha frequency lower with alpha/theta protocolReward 9-10Hz alpha at Pz, shift alpha frequency lower with alpha/theta protocol

Spindling excessive beta Spindling excessive beta High frequency beta with a spindle morphology, often with an anterior emphasis.High frequency beta with a spindle morphology, often with an anterior emphasis. AnticonvulsantsAnticonvulsants Inhibit beta frequencies, wide band inhibit, possibly Penniston if alpha levels are depressed.Inhibit beta frequencies, wide band inhibit, possibly Penniston if alpha levels are depressed.

Persistent alpha with eyes openPersistent alpha with eyes open Lack of appreciable alpha blocking with eye opening, generally this is slower alpha Lack of appreciable alpha blocking with eye opening, generally this is slower alpha

SNRI or amphetamine SNRI or amphetamine Reward beta frequencies, inhibit alpha. Reward higher frequency alpha.Reward beta frequencies, inhibit alpha. Reward higher frequency alpha.

Page 16: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Diffuse slow activity, with or without low frequency alpha.Diffuse slow activity, with or without low frequency alpha. Increased delta and theta (1-7 Hz) with or without slow posterior dominant rhythm StimulantIncreased delta and theta (1-7 Hz) with or without slow posterior dominant rhythm Stimulant

Inhibit midline frontocentral activity below 10 Hz., add reward anterior beta frequencies for increased Inhibit midline frontocentral activity below 10 Hz., add reward anterior beta frequencies for increased effecteffect

Focal abnormalities, not epileptiform.Focal abnormalities, not epileptiform. Focal slow activity or focal lack of activity. Focal slow activity or focal lack of activity. Inhibit slow activity (<10 Hz) and reward higher frequencies(> 12 Hz).Inhibit slow activity (<10 Hz) and reward higher frequencies(> 12 Hz).

Mixed fast and slowMixed fast and slow Increased activity below 8 Hz., lack of alpha, increased beta frequency activity Combine across Increased activity below 8 Hz., lack of alpha, increased beta frequency activity Combine across

classes, e.g. stimulant + anticonvulsant classes, e.g. stimulant + anticonvulsant Inhibit slow frequencies, reward SMR. Inhibit slow frequencies, reward SMR.

Frontally dominant excess theta or alpha frequency activityFrontally dominant excess theta or alpha frequency activity Antidepressant, stimulant Antidepressant, stimulant Inhibit midline frontocentral activity below 10 Hz., add reward anterior beta frequencies for increased Inhibit midline frontocentral activity below 10 Hz., add reward anterior beta frequencies for increased

effecteffect

Frontal asymmetriesFrontal asymmetries Variable asymmetry L>R or R>L, primarily at F3, F4. Variable asymmetry L>R or R>L, primarily at F3, F4. Antidepressant Antidepressant Reward F3 beta, inhibit F3 theta and alpha frequencies.Reward F3 beta, inhibit F3 theta and alpha frequencies.

Excess temporal lobe alphaExcess temporal lobe alpha Increased alpha activity generated in temporal lobe Increased alpha activity generated in temporal lobe Stimulant Stimulant Inhibit 9-12 Hz activity over affected temporal region(s), + inhibit frontal slow activity.Inhibit 9-12 Hz activity over affected temporal region(s), + inhibit frontal slow activity.

Page 17: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 18: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Slow variantSlow variant

Page 19: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Epileptiform (myoclonus)Epileptiform (myoclonus)

Page 20: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 21: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Beta spindleBeta spindle

Page 22: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Failure of alpha blockingFailure of alpha blockingFp1

Fp2

F3

F4

C3

C4

P3

P4

O1

O2

F7

F8

T3

T4

T5

T6

Fz

Cz

Pz

20

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

50 µV

Page 23: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 24: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 25: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 26: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Addiction outcomes are about more than Addiction outcomes are about more than sobriety… a dry drunk is not “cured”… we sobriety… a dry drunk is not “cured”… we

look for “optimal function” when the look for “optimal function” when the “brain works better”.“brain works better”.

Page 27: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 28: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Big data meets EEG/qEEG

Page 29: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Beta spindles: N=390 Beta spindles: N=390 (with 49 ADHD)(with 49 ADHD)

Page 30: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate
Page 31: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

REFERENCESREFERENCES

John ER, Prichep LS, Almas M. Sub typing of Psychiatric Patients by Cluster Analysis of QEEG. John ER, Prichep LS, Almas M. Sub typing of Psychiatric Patients by Cluster Analysis of QEEG. Brain Topography 1992; 4:321-326.Brain Topography 1992; 4:321-326.

Nelson LA. Neurotherapy and the challenge of empirical support: A call for a neurotherapy Nelson LA. Neurotherapy and the challenge of empirical support: A call for a neurotherapy practice research network. Journal of Neurotherapy; 2003:7(2) 53-67.practice research network. Journal of Neurotherapy; 2003:7(2) 53-67.

Yucha C, Gilbert C. Evidence-based practice in biofeedback and neurofeedback. Association of Yucha C, Gilbert C. Evidence-based practice in biofeedback and neurofeedback. Association of Applied Psychophysiology and Biofeedback (Applied Psychophysiology and Biofeedback (www.aapb.org))

Suffin SC, Emory WH. Neurometric subgroups in attentional and affective disorders and their Suffin SC, Emory WH. Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome. Clinical Electroencephalography 1995; 26:76-association with pharmacotherapeutic outcome. Clinical Electroencephalography 1995; 26:76-83.83.

Leuchter AF, Cook IA, Morgan ML, Witte EA, Abrams M. Changes in brain function of depressed Leuchter AF, Cook IA, Morgan ML, Witte EA, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 2002; 159(1):122-129.subjects during treatment with placebo. American Journal of Psychiatry 2002; 159(1):122-129.

Porjesz B, Almasy L, Edenberg HJ, Wang K, Chorlian DB, Foroud T, Goate A, Rice JP, O'Connor SJ, Porjesz B, Almasy L, Edenberg HJ, Wang K, Chorlian DB, Foroud T, Goate A, Rice JP, O'Connor SJ, Rohrbaugh J, Kuperman S, Bauer LO, Crowe RR, Schuckit MA, Hesselbrock V, Conneally PM, Rohrbaugh J, Kuperman S, Bauer LO, Crowe RR, Schuckit MA, Hesselbrock V, Conneally PM, Tischfield JA, Li T-K, Reich T, Begleiter H.S. Linkage disequilibrium between the beta frequency of Tischfield JA, Li T-K, Reich T, Begleiter H.S. Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus. Proceedings of the National Academy of the human EEG and a GABAA receptor gene locus. Proceedings of the National Academy of Sciences of the United States of America 2002; 99(6): 3729-3733.Sciences of the United States of America 2002; 99(6): 3729-3733.

Enoch MA, White KV, Harris CR, Rohrbaugh JW, Goldman D. The relationship between two Enoch MA, White KV, Harris CR, Rohrbaugh JW, Goldman D. The relationship between two intermediate phenotypes for alcoholism: low voltage alpha EEG and low P300 ERP amplitude. intermediate phenotypes for alcoholism: low voltage alpha EEG and low P300 ERP amplitude. Journal of Study of Alcohol 2002; 63(5):509-517.Journal of Study of Alcohol 2002; 63(5):509-517.

Huag K, Warnstedt M, Alekov AK, Sander T, Ramirez A, Poser B, Maljevic S, Hebeisen S, Kubisch Huag K, Warnstedt M, Alekov AK, Sander T, Ramirez A, Poser B, Maljevic S, Hebeisen S, Kubisch C, Rebstock J, Horvath S, Hallman K, Dullinger JS, Rau B, Haverkamp F, Beyenburg S, Schulz H, C, Rebstock J, Horvath S, Hallman K, Dullinger JS, Rau B, Haverkamp F, Beyenburg S, Schulz H, Janz D, Giese B, Muller-Newen G, Propping P, Elger CE, Fahlke C, Lerche H, Heils A. Mutations in Janz D, Giese B, Muller-Newen G, Propping P, Elger CE, Fahlke C, Lerche H, Heils A. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nature Genetics 2003; 33:527-532.epilepsies. Nature Genetics 2003; 33:527-532.

Page 32: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Phillips C. Electrophysiology in the study of developmental language impairments: Phillips C. Electrophysiology in the study of developmental language impairments: prospects and challenges for a top-down approach. Applied Psycholinguistics (in prospects and challenges for a top-down approach. Applied Psycholinguistics (in press)press)

Light GA, Braff DL. Human and animal studies of schizophrenia-related gating Light GA, Braff DL. Human and animal studies of schizophrenia-related gating deficits. Current Psychiatry Reports 1999; 1:31-40.deficits. Current Psychiatry Reports 1999; 1:31-40.

Johnstone J, Gunkelman J. Use of databases in QEEG evaluation. Journal of Johnstone J, Gunkelman J. Use of databases in QEEG evaluation. Journal of Neurotherapy 2003; 7(3/4):31-52.Neurotherapy 2003; 7(3/4):31-52.

Lorensen TD, Dickson P. Quantitative EEG databases: A comparative Lorensen TD, Dickson P. Quantitative EEG databases: A comparative investigation. Journal of Neurotherapy 2003; 7(3/4):53-68.investigation. Journal of Neurotherapy 2003; 7(3/4):53-68.

Chabot RJ, Serfontein G. Quantitative electroencephalographic profiles of children Chabot RJ, Serfontein G. Quantitative electroencephalographic profiles of children with attention deficit disorder. Biological Psychiatry 1996; 40:951-963. with attention deficit disorder. Biological Psychiatry 1996; 40:951-963.

Chabot RJ, Merkin H, Wood LM, Davenport TL, Serfontein G. Sensitivity and Chabot RJ, Merkin H, Wood LM, Davenport TL, Serfontein G. Sensitivity and specificity of QEEG in children with attention deficit or specific developmental specificity of QEEG in children with attention deficit or specific developmental learning disorders. Clinical EEG 1996; 27:26-34.learning disorders. Clinical EEG 1996; 27:26-34.

Chabot RJ, Merkin H, Wood L, Davenport T, Serfontein G. Quantitative EEG profiles Chabot RJ, Merkin H, Wood L, Davenport T, Serfontein G. Quantitative EEG profiles of children with attention and learning disorders and the role of QEEG in predicting of children with attention and learning disorders and the role of QEEG in predicting medication response and outcome. Society for Neuronal Regulation, 5th Annual medication response and outcome. Society for Neuronal Regulation, 5th Annual Meeting, September 18-21, 1997 Aspen, CO. Meeting, September 18-21, 1997 Aspen, CO.

Chabot RJ, di Michele F, Prichep L, John ER. The clinical role of computerized EEG Chabot RJ, di Michele F, Prichep L, John ER. The clinical role of computerized EEG in the evaluation and treatment of learning and attention disorders in children and in the evaluation and treatment of learning and attention disorders in children and adolescents. Neuropsychiatry and Clinical Neuroscience 2001; 13(2):171-186.adolescents. Neuropsychiatry and Clinical Neuroscience 2001; 13(2):171-186.

Fein G, Galin D, Yingling CD, Johnstone J, Nelson MA. EEG spectra in 9-13-year-old Fein G, Galin D, Yingling CD, Johnstone J, Nelson MA. EEG spectra in 9-13-year-old boys are stable over 1-3 years. Electroencephalography and Clinical boys are stable over 1-3 years. Electroencephalography and Clinical Neurophysiology 1984; 58(6):517-518.Neurophysiology 1984; 58(6):517-518.

Niedermeyer E, Lopes Da Silva F (Eds). EEG patterns and genetics, In: Niedermeyer E, Lopes Da Silva F (Eds). EEG patterns and genetics, In: Electroencephalography: basic principles, clinical applications and related fields, Electroencephalography: basic principles, clinical applications and related fields, 3rd edition, Baltimore: Lippincott, Williams & Wilkins, 1993, 192-195.3rd edition, Baltimore: Lippincott, Williams & Wilkins, 1993, 192-195.

Vogel F. Genetics and the Electroencephalogram. New York: Springer-Verlag Telos, Vogel F. Genetics and the Electroencephalogram. New York: Springer-Verlag Telos, 2000.2000.

Page 33: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Vogel F. Genetics and the Electroencephalogram. New York: Springer-Verlag Telos, Vogel F. Genetics and the Electroencephalogram. New York: Springer-Verlag Telos, 2000.2000.

Van Beijsterveldt CE, Van Baal GC. Twin and family studies of the human Van Beijsterveldt CE, Van Baal GC. Twin and family studies of the human electroencephalogram: a review and a meta-analysis. Biological Psychology 2002; electroencephalogram: a review and a meta-analysis. Biological Psychology 2002; 61(1-2):111-38.61(1-2):111-38.

Gunkelman J. Evaluating the frontal lobes in affective and attentional disorders Gunkelman J. Evaluating the frontal lobes in affective and attentional disorders with QEEG and EP - the electrophysiology of frontal lobe disconnection syndrome: with QEEG and EP - the electrophysiology of frontal lobe disconnection syndrome: implications for neurotherapy. Journal of Neurotherapy 1998.implications for neurotherapy. Journal of Neurotherapy 1998.

Cook IA, O'Hara R, Uijtdehaage SH, Mandelkern M, Leuchter AF. Assessing the Cook IA, O'Hara R, Uijtdehaage SH, Mandelkern M, Leuchter AF. Assessing the accuracy of topographic EEG mapping for determining local brain function. accuracy of topographic EEG mapping for determining local brain function. Electroencephalography and Clinical Neurophysiology 1998; 107(6):408-414.Electroencephalography and Clinical Neurophysiology 1998; 107(6):408-414.

Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, De Caria CM, Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, De Caria CM, Levine RH. Quantitative electroencephalographic subtyping of obsessive-Levine RH. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Research 1993; 50(1):25-32.compulsive disorder. Psychiatry Research 1993; 50(1):25-32.

Wright C, Gunkelman J. QEEG evaluation doubles the rate of clinical success. Wright C, Gunkelman J. QEEG evaluation doubles the rate of clinical success. Series data and case studies. Abstracts 6th Annual Conference, Society for the Series data and case studies. Abstracts 6th Annual Conference, Society for the Study of Neuronal Regulation, September 10-13, 1998, Austin, TX.Study of Neuronal Regulation, September 10-13, 1998, Austin, TX.

Budzynski TH. Reversing age-related cognitive decline: Use of neurofeedback and Budzynski TH. Reversing age-related cognitive decline: Use of neurofeedback and audio-visual stimulation. Biofeedback 2000; 28:19-21.audio-visual stimulation. Biofeedback 2000; 28:19-21.

Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Research and Brain Research Review performance: a review and analysis. Brain Research and Brain Research Review 1999; 29(2-3), 169-195.1999; 29(2-3), 169-195.

Losifescu D, Greenwald S, Devlin P, Alpert J, Hamill S, Fava M. Frontal EEG Losifescu D, Greenwald S, Devlin P, Alpert J, Hamill S, Fava M. Frontal EEG Predicts Clinical Response to SSRI Treatment in MDD. 44th Annual NCDEU, June, Predicts Clinical Response to SSRI Treatment in MDD. 44th Annual NCDEU, June, 2004, Phoenix, AZ2004, Phoenix, AZ

Rosenfeld JP. EEG biofeedback of frontal alpha asymmetry in affective disorders. Rosenfeld JP. EEG biofeedback of frontal alpha asymmetry in affective disorders. Biofeedback 1997; 5(1) 8-25.Biofeedback 1997; 5(1) 8-25.

Lawson R. Different measure of anterior EEG asymmetry and depression severity: Lawson R. Different measure of anterior EEG asymmetry and depression severity: continuous performance task, grade point average, and self-report scales. Society continuous performance task, grade point average, and self-report scales. Society for Neuronal Regulation, 2000.for Neuronal Regulation, 2000.

Perrin F, Bertrand O, Pernier J. Scalp current density mapping: value and Perrin F, Bertrand O, Pernier J. Scalp current density mapping: value and estimation from potential data. IEEE Transactions on Biomedical Engineering estimation from potential data. IEEE Transactions on Biomedical Engineering 1987; 34(4):283-288.1987; 34(4):283-288.

Srinivasan R, Nunez PL, Tucker DM, Silberstein RB, Caducsh PJ. Spatial sampling Srinivasan R, Nunez PL, Tucker DM, Silberstein RB, Caducsh PJ. Spatial sampling and filtering of EEG with spline Laplacians to estimate cortical potentials. Brain and filtering of EEG with spline Laplacians to estimate cortical potentials. Brain Topography 1996; 8(4):355-366.Topography 1996; 8(4):355-366.

Page 34: The Midwest Society for Behavioral Medicine and Biofeedback (MSBMB) DSM-5 and Biomarkers/Phenotypes Jay Gunkelman, QEEG-Diplomate Jay Gunkelman, QEEG-Diplomate

Sterman MB. Basic concepts and clinical findings in the Sterman MB. Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning. treatment of seizure disorders with EEG operant conditioning. Clinical Electroencephalography 2000; 31(1):45-55.Clinical Electroencephalography 2000; 31(1):45-55.

Lantz D, Sterman MB. Neuropsychological assessment of Lantz D, Sterman MB. Neuropsychological assessment of subjects with uncontrolled epilepsy: effects of EEG biofeedback subjects with uncontrolled epilepsy: effects of EEG biofeedback training. Epilepsia 1998; 29(2):163-171.training. Epilepsia 1998; 29(2):163-171.

Birbaumer N, Elbert T, Rockstroh B et al. Biofeedback of event-Birbaumer N, Elbert T, Rockstroh B et al. Biofeedback of event-related slow potentials of the brain. International Journal of related slow potentials of the brain. International Journal of Psychology 1981; 16:389-415.Psychology 1981; 16:389-415.

Gibbs FA, Gibbs EL. Atlas of electroencephalography. Reading Gibbs FA, Gibbs EL. Atlas of electroencephalography. Reading MA: Addison-Wesley, 1950.MA: Addison-Wesley, 1950.

Niedermeyer E, Lopes Da Silva F (Eds). Electroencephalography: Niedermeyer E, Lopes Da Silva F (Eds). Electroencephalography: Basic Principles, Clinical Applications, and Related Fields, 4th Basic Principles, Clinical Applications, and Related Fields, 4th edition, Baltimore: Lippincott, Williams & Wilkins, 1999.edition, Baltimore: Lippincott, Williams & Wilkins, 1999.

Prichep LS, John ER. QEEG profiles of psychiatric disorders. Brain Prichep LS, John ER. QEEG profiles of psychiatric disorders. Brain Topography 1992; 4(4):249-257.Topography 1992; 4(4):249-257.

Donaldson S. Society for Neuronal Regulation Annual Meeting, Donaldson S. Society for Neuronal Regulation Annual Meeting, Scottsdale, AZ., 2002.Scottsdale, AZ., 2002.

Gunkelman J. Low voltage or absolute power. Journal of Gunkelman J. Low voltage or absolute power. Journal of Neurotherapy 2001; 5:1-2.Neurotherapy 2001; 5:1-2.

Kolb, B. and Whishaw, I. Fundamentals of Human Kolb, B. and Whishaw, I. Fundamentals of Human Neuropsychology, 5th Edition, New York, NY: W.H. Neuropsychology, 5th Edition, New York, NY: W.H.